UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 161 filers reported holding UNIQURE NV in Q3 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $648 | -99.9% | 56,584 | +145.4% | 0.05% | -29.0% |
| Q2 2021 | $710,000 | +65.9% | 23,060 | +94.9% | 0.07% | +50.0% |
| Q4 2020 | $428,000 | -51.6% | 11,833 | -39.7% | 0.05% | -54.9% |
| Q2 2020 | $884,000 | +22.1% | 19,614 | +6.6% | 0.10% | +82.1% |
| Q3 2019 | $724,000 | +49.3% | 18,399 | +196.6% | 0.06% | +100.0% |
| Q2 2019 | $485,000 | +1.7% | 6,204 | -22.5% | 0.03% | +3.7% |
| Q1 2019 | $477,000 | +12.2% | 8,001 | -31.6% | 0.03% | +3.8% |
| Q3 2018 | $425,000 | – | 11,689 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |